ONB
ACAD icon

Old National Bancorp’s Acadia Pharmaceuticals ACAD Stock Holding History

Old National Bancorp’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,122
Closed -$215K – 613
2015
Q2 		$215K Buy
+5,122
New +$198K 0.01% 580
2015
Q1 		– Sell
-6,490
Closed -$206K – 790
2014
Q4 		$206K Buy
+6,490
New +$184K 0.01% 546

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Old National Bancorp's ACAD Position: Q3 2015 in Review

Old National Bancorp sold out of Acadia Pharmaceuticals (ACAD) in Q3 2015, closing a stake of 5,122 shares — an estimated $215K sold.

Old National Bancorp first reported a position in ACAD in Q4 2014 and held it in 2 quarters. The position peaked at $215K in Q2 2015. 188 funds tracked by Wall St. Rank hold ACAD as of Q3 2015.

  • Old National Bancorp reported no remaining Acadia Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Old National Bancorp sold 5,122 Acadia Pharmaceuticals shares in Q3 2015, an estimated $215K.
  • Old National Bancorp first reported a position in Acadia Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Old National Bancorp's Acadia Pharmaceuticals position peaked at $215K in Q2 2015.
  • 188 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2015.

Based on Old National Bancorp's 13F filing for Q3 2015, filed 23 Nov 2015.